COVID‐19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry—Communication from the ISTH SSC for Women’s Health
Rezan A. Kadir(The Royal Free Hospital), Maha Othman(Mansoura University), Ann Kinga Malinowski(Mount Sinai Hospital), Takao Kobayashi(Hokkaido University), Jecko Thachil(University of Manchester), Offer Erez(Soroka Medical Center), Sajida Kazi(University of Edinburgh), Toshiaki Iba(Juntendo University)
Cited by 71
Related Papers
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
|The Lancet|2021|564
IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs
|The Journal of Immunology|2011|552
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
|The Lancet|2021|523
The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses
|The Journal of Immunology|2011|490
The coagulopathy, endotheliopathy, and vasculitis of COVID-19
|Inflammation Research|2020|437